BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

479 related articles for article (PubMed ID: 16894514)

  • 1. The epidemiological profile of infections with multidrug-resistant Pseudomonas aeruginosa and Acinetobacter species.
    Paterson DL
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S43-8. PubMed ID: 16894514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Four years of monitoring of antibiotic sensitivity rates of Pseudomonas aeruginosa and Acinetobacter baumannii strains isolated from patients in intensive care unit and inpatient clinics].
    Alişkan H; Colakoğlu S; Turunç T; Demiroğlu YZ; Erdoğan F; Akin S; Arslan H
    Mikrobiyol Bul; 2008 Apr; 42(2):321-9. PubMed ID: 18697430
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pseudomonas aeruginosa infections in the Intensive Care Unit: can the adequacy of empirical beta-lactam antibiotic therapy be improved?
    Bhat S; Fujitani S; Potoski BA; Capitano B; Linden PK; Shutt K; Paterson DL
    Int J Antimicrob Agents; 2007 Nov; 30(5):458-62. PubMed ID: 17703923
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
    Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New treatment options for infections caused by multiresistant strains of Pseudomonas aeruginosa and other nonfermenting gram-negative bacilli.
    Sánchez A; Gattarello S; Rello J
    Semin Respir Crit Care Med; 2011 Apr; 32(2):151-8. PubMed ID: 21506051
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Emerging resistant Gram-negative aerobic bacilli in hospital-acquired infections.
    Kunz AN; Brook I
    Chemotherapy; 2010; 56(6):492-500. PubMed ID: 21099222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel antibiotic combinations against infections with almost completely resistant Pseudomonas aeruginosa and Acinetobacter species.
    Rahal JJ
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S95-9. PubMed ID: 16894522
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Evaluation of antibiotic resistance patterns of Pseudomonas aeruginosa and Acinetobacter spp. strains isolated from intensive care patients between 2000-2002 and 2003-2006 periods in Dokuz Eylul University Hospital, Izmir].
    Yüce A; Yapar N; Eren Kutsoylu O
    Mikrobiyol Bul; 2009 Apr; 43(2):195-202. PubMed ID: 19621603
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Stable carbapenem susceptibility rates among multidrug-resistant Acinetobacter spp. strains in a setting of high prevalence of carbapenem-resistant Pseudomonas aeruginosa.
    Zavascki AP; Soares FC; Superti SV; Silbert S; Silva FM; Barth AL
    Int J Antimicrob Agents; 2007 Aug; 30(2):187-9. PubMed ID: 17452093
    [No Abstract]   [Full Text] [Related]  

  • 11. Mechanisms of multidrug resistance in Acinetobacter species and Pseudomonas aeruginosa.
    Bonomo RA; Szabo D
    Clin Infect Dis; 2006 Sep; 43 Suppl 2():S49-56. PubMed ID: 16894515
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Microbiology and drug resistance mechanisms of fully resistant pathogens.
    Walsh FM; Amyes SG
    Curr Opin Microbiol; 2004 Oct; 7(5):439-44. PubMed ID: 15451497
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Superbugs in the coming new decade; multidrug resistance and prospects for treatment of Staphylococcus aureus, Enterococcus spp. and Pseudomonas aeruginosa in 2010.
    Nordmann P; Naas T; Fortineau N; Poirel L
    Curr Opin Microbiol; 2007 Oct; 10(5):436-40. PubMed ID: 17765004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Multidrug resistant Acinetobacter baumannii].
    Nemec A
    Klin Mikrobiol Infekc Lek; 2008 Oct; 14(5):162-7. PubMed ID: 19051163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acinetobacter baumannii: an emerging multidrug-resistant threat.
    Gootz TD; Marra A
    Expert Rev Anti Infect Ther; 2008 Jun; 6(3):309-25. PubMed ID: 18588496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and antibiotic susceptibility of Acinetobacter baumannii, Pseudomonas aeruginosa and Klebsiella pneumoniae in Estonian intensive care units in comparison with European data.
    Lõivukene K; Sepp E; Adamson V; Mitt P; Kallandi U; Otter K; Naaber P
    Scand J Infect Dis; 2006; 38(11-12):1001-8. PubMed ID: 17148068
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kwa AL; Loh C; Low JG; Kurup A; Tam VH
    Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nosocomial urinary tract infections caused by Pseudomonas aeruginosa and Acinetobacter species: sensitivity to antibiotics and risk factors.
    Djordjevic Z; Folic MM; Zivic Z; Markovic V; Jankovic SM
    Am J Infect Control; 2013 Dec; 41(12):1182-7. PubMed ID: 23726656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metallo beta lactamases in Pseudomonas aeruginosa and Acinetobacter species.
    Gupta V
    Expert Opin Investig Drugs; 2008 Feb; 17(2):131-43. PubMed ID: 18230049
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Emergence and spread of carbapenem-resistant strains of Acinetobacter baumannii in a tertiary-care hospital in Poland.
    Wroblewska MM; Towner KJ; Marchel H; Luczak M
    Clin Microbiol Infect; 2007 May; 13(5):490-6. PubMed ID: 17331123
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 24.